364 related articles for article (PubMed ID: 16185098)
1. Male hypogonadism : an update on diagnosis and treatment.
Darby E; Anawalt BD
Treat Endocrinol; 2005; 4(5):293-309. PubMed ID: 16185098
[TBL] [Abstract][Full Text] [Related]
2. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.
Petak SM; Nankin HR; Spark RF; Swerdloff RS; Rodriguez-Rigau LJ;
Endocr Pract; 2002; 8(6):440-56. PubMed ID: 15260010
[TBL] [Abstract][Full Text] [Related]
3. Testosterone therapy--what, when and to whom?
Jockenhövel F
Aging Male; 2004 Dec; 7(4):319-24. PubMed ID: 15799128
[TBL] [Abstract][Full Text] [Related]
4. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
[TBL] [Abstract][Full Text] [Related]
5. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
Borst SE; Yarrow JF
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
[TBL] [Abstract][Full Text] [Related]
7. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract][Full Text] [Related]
8. An update on male hypogonadism therapy.
Surampudi P; Swerdloff RS; Wang C
Expert Opin Pharmacother; 2014 Jun; 15(9):1247-64. PubMed ID: 24758365
[TBL] [Abstract][Full Text] [Related]
9. Hormone substitution in male hypogonadism.
Zitzmann M; Nieschlag E
Mol Cell Endocrinol; 2000 Mar; 161(1-2):73-88. PubMed ID: 10773395
[TBL] [Abstract][Full Text] [Related]
10. Testosterone supplementation: what and how to give.
Jockenhövel F
Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500
[TBL] [Abstract][Full Text] [Related]
11. Androgen replacement therapy: present and future.
Gooren LJ; Bunck MC
Drugs; 2004; 64(17):1861-91. PubMed ID: 15329035
[TBL] [Abstract][Full Text] [Related]
12. Current topics in testosterone replacement of hypogonadal men.
Nieschlag E
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
[TBL] [Abstract][Full Text] [Related]
13. Point: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male.
Heaton JP
Can J Urol; 2002 Dec; 9(6):1677-80. PubMed ID: 12517308
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
Raynaud JP; Gardette J; Rollet J; Legros JJ
BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
[TBL] [Abstract][Full Text] [Related]
16. Effects of testosterone replacement in hypogonadal men.
Snyder PJ; Peachey H; Berlin JA; Hannoush P; Haddad G; Dlewati A; Santanna J; Loh L; Lenrow DA; Holmes JH; Kapoor SC; Atkinson LE; Strom BL
J Clin Endocrinol Metab; 2000 Aug; 85(8):2670-7. PubMed ID: 10946864
[TBL] [Abstract][Full Text] [Related]
17. New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men.
Karakas SE; Surampudi P
Adv Clin Chem; 2018; 86():71-125. PubMed ID: 30144842
[TBL] [Abstract][Full Text] [Related]
18. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
19. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
[TBL] [Abstract][Full Text] [Related]
20. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.
Zitzmann M; Mattern A; Hanisch J; Gooren L; Jones H; Maggi M
J Sex Med; 2013 Feb; 10(2):579-88. PubMed ID: 22812645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
